User profiles for Kristoffer Marsaa

Kristoffer Marsaa

Chief physician, Department of Multi disease, Copenhagen University Hospital – North …
Verified email at dadlnet.dk
Cited by 565

COVID-19: guidance on palliative care from a European Respiratory Society international task force

…, AK Simonds, T Tonia, K Marsaa - European respiratory …, 2020 - Eur Respiratory Soc
Background Many people are dying from coronavirus disease 2019 (COVID-19), but consensus
guidance on palliative care in COVID-19 is lacking. This new life-threatening disease …

The lived experience with idiopathic pulmonary fibrosis: a qualitative study

D Overgaard, G Kaldan, K Marsaa… - European …, 2016 - Eur Respiratory Soc
The disease course in idiopathic pulmonary fibrosis (IPF) is variable, but patients experience
a progressive decline in lung function and increased symptom burden leading to death. …

Pride and uncertainty: a qualitative study of Danish nursing staff in temporary COVID-19 wards

K Marsaa, J Mendahl, H Heilman… - Journal of Hospice & …, 2021 - journals.lww.com
There is limited knowledge about the psychosocial stress among the nursing staff working
on the COVID-19 wards. This article reports on the experiences of frontline health care …

European Respiratory Society clinical practice guideline: palliative care for people with COPD or interstitial lung disease

…, ST Simon, T Tonia, K Marsaa - European …, 2023 - Eur Respiratory Soc
There is increased awareness of palliative care needs in people with COPD or interstitial
lung disease (ILD). This European Respiratory Society (ERS) task force aimed to provide …

European Respiratory Society Clinical Practice Guideline: Palliative care for people with chronic obstructive pulmonary disease or interstitial lung disease

…, ST Simon, T Tonia, K Marsaa - European …, 2023 - Eur Respiratory Soc
There is increased awareness of palliative care needs in people with chronic obstructive
pulmonary disease (COPD) or interstitial lung disease (ILD). This European Respiratory Society …

[HTML][HTML] Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD

NS Godtfredsen, DV Jørgensen, K Marsaa, CS Ulrik… - Respiratory …, 2018 - Springer
Background The inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR)
is elevated in severe acute and chronic medical conditions and has been …

Attitude and barriers in palliative care and advance care planning in nonmalignant chronic lung disease: results from a Danish national survey

AR Sørensen, K Marsaa, TS Prior… - Journal of palliative …, 2020 - journals.sagepub.com
Introduction: Patients with chronic obstructive pulmonary disease and interstitial lung disease
have a significant burden of symptoms. Many are not offered palliative care (PC). Our aim …

Prevalence and management of pulmonary comorbidity in patients with lung and head and neck cancer

M Gottlieb, K Marsaa, NS Godtfredsen… - Acta …, 2015 - Taylor & Francis
Background. The simultaneous presence of cancer and other medical conditions (comorbidity)
is frequent. Cigarette smoking is the major risk factor for as well head and neck cancer (…

[HTML][HTML] Regional and age differences in specialised palliative care for patients with pancreatic cancer

…, JS Johansen, M Nissen, M Groenvold, K Marsaa - BMC Palliative Care, 2021 - Springer
Background Despite national recommendations, disparities in specialised palliative care (SPC)
admittance have been reported. The aims of this study were to characterize SPC …

Danish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases

K Marsaa, S Gundestrup, JU Jensen… - European Clinical …, 2018 - Taylor & Francis
Background: Chronic non-malignant lung diseases such as chronic obstructive pulmonary
disease (COPD) and interstitial lung diseases (ILD) result in reduced quality of life (QoL), a …